Published in EMBO Rep on December 01, 2011
Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J (2011) 4.00
Dynamical malaria models reveal how immunity buffers effect of climate variability. Proc Natl Acad Sci U S A (2015) 1.52
Influence of iron status on risk of maternal or neonatal infection and on neonatal mortality with an emphasis on developing countries. Nutr Rev (2013) 1.00
The effect of timing of iron supplementation on iron absorption and haemoglobin in post-malaria anaemia: a longitudinal stable isotope study in Malawian toddlers. Malar J (2014) 0.88
The Iron age of host-microbe interactions. EMBO Rep (2015) 0.85
Decline in childhood iron deficiency after interruption of malaria transmission in highland Kenya. Am J Clin Nutr (2014) 0.81
Malaria and immunity during pregnancy and postpartum: a tale of two species. Parasitology (2015) 0.80
The iron link between malaria and invasive non-typhoid Salmonella infections. Trends Parasitol (2013) 0.79
Erythroferrone contributes to hepcidin repression in a mouse model of malarial anemia. Haematologica (2016) 0.76
Systematic tracking of altered haematopoiesis during sporozoite-mediated malaria development reveals multiple response points. Open Biol (2016) 0.75
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science (2004) 19.19
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest (2004) 11.05
A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem (2000) 8.52
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature (2000) 7.46
Malaria transmission in urban sub-Saharan Africa. Am J Trop Med Hyg (2003) 6.28
Acquired immunity to malaria. Clin Microbiol Rev (2009) 6.24
The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv Parasitol (2002) 6.01
The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab (2005) 5.32
A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell (2000) 5.31
A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem (2000) 5.21
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med (2007) 5.18
Iron and microbial infection. Nat Rev Microbiol (2004) 4.53
Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet (2003) 4.49
Protection against a malaria challenge by sporozoite inoculation. N Engl J Med (2009) 4.03
Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet (2008) 4.02
Immune effector mechanisms in malaria. Parasite Immunol (2006) 3.43
Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am J Trop Med Hyg (1975) 3.32
Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med (1992) 3.30
Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet (2011) 2.98
The silent path to thousands of merozoites: the Plasmodium liver stage. Nat Rev Microbiol (2006) 2.83
Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children. Trans R Soc Trop Med Hyg (2000) 2.70
Hepcidin and disorders of iron metabolism. Annu Rev Med (2011) 2.67
Host-mediated regulation of superinfection in malaria. Nat Med (2011) 2.57
High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand. Lancet (1987) 2.52
Cross-species interactions between malaria parasites in humans. Science (2000) 2.43
Malarial anemia: of mice and men. Blood (2007) 2.27
Plasmodium falciparum malaria and Salmonella infections in Gambian children. J Infect Dis (1987) 2.23
Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity. Malar J (2009) 2.19
Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. J Clin Invest (2010) 2.18
Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology (2010) 2.17
The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. Trends Parasitol (2004) 2.16
Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood (2005) 2.02
A research agenda for malaria eradication: basic science and enabling technologies. PLoS Med (2011) 1.89
Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis. Science (2011) 1.88
Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo. Blood (2006) 1.83
Malaria blood stage suppression of liver stage immunity by dendritic cells. J Exp Med (2003) 1.78
A decline in the incidence of invasive non-typhoidal Salmonella infection in The Gambia temporally associated with a decline in malaria infection. PLoS One (2010) 1.72
Reduced risk of clinical malaria in children infected with multiple clones of Plasmodium falciparum in a highly endemic area: a prospective community study. Trans R Soc Trop Med Hyg (1998) 1.71
Mixed-species Plasmodium infections of humans. J Parasitol (1997) 1.69
Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J Clin Invest (1991) 1.68
Hepcidin regulation by innate immune and infectious stimuli. Blood (2011) 1.63
Assessment of urinary concentrations of hepcidin provides novel insight into disturbances in iron homeostasis during malarial infection. J Infect Dis (2009) 1.63
Viral infection and iron metabolism. Nat Rev Microbiol (2008) 1.61
Interactions between malaria parasites infecting the same vertebrate host. Parasitology (1988) 1.59
Malarial immunity in Africans; effects in infancy and early childhood. Ann Trop Med Parasitol (1949) 1.56
Both hemolytic anemia and malaria parasite-specific factors increase susceptibility to Nontyphoidal Salmonella enterica serovar typhimurium infection in mice. Infect Immun (2010) 1.54
Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia. Blood (1992) 1.53
Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage. J Immunol (2008) 1.53
Plasmodium falciparum multiple infections in Mozambique, its relation to other malariological indices and to prospective risk of malaria morbidity. Trop Med Int Health (2003) 1.53
The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol (2007) 1.51
Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob Agents Chemother (1993) 1.50
Molecular epidemiology of Plasmodium falciparum infections among asymptomatic inhabitants of a holoendemic malarious area in northern Ghana. Trop Med Int Health (2002) 1.50
The effect of the host's iron status on tuberculosis. J Infect Dis (2007) 1.49
Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria. Haematologica (2010) 1.47
Age and seasonal variation in the transition rates and detectability of Plasmodium falciparum malaria. Parasitology (2006) 1.40
Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine. Am J Trop Med Hyg (1982) 1.39
The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infect Immun (2006) 1.38
Identification of malaria species by ELISA in sporozoite and oocyst infected Anopheles from western Kenya. Am J Trop Med Hyg (1988) 1.25
Cross-species regulation of Plasmodium parasitemia in semi-immune children from Papua New Guinea. Trends Parasitol (2003) 1.25
Desferrioxamine suppresses Plasmodium falciparum in Aotus monkeys. Proc Soc Exp Biol Med (1987) 1.23
Relationship of hepcidin with parasitemia and anemia among patients with uncomplicated Plasmodium falciparum malaria in Ghana. Am J Trop Med Hyg (2007) 1.22
Refeeding-malaria and hyperferraemia. Lancet (1975) 1.22
Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection. Br J Haematol (2009) 1.19
Malaria outbreaks in new foci in Sri Lanka. Parasitol Today (1988) 1.18
Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial. PLoS One (2011) 1.16
Bone marrow macrophage iron grade and survival of HIV-seropositive patients. AIDS (1999) 1.12
Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research priorities. PLoS Negl Trop Dis (2008) 1.10
In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum. J Antimicrob Chemother (2006) 1.08
Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria. Trans R Soc Trop Med Hyg (1998) 1.07
Development of the RTS,S/AS malaria candidate vaccine. Vaccine (2009) 1.05
Plasmodium vinckei: suppression of mouse infections with desferrioxamine B. Exp Parasitol (1985) 1.05
Genetic diversity of Plasmodium falciparum in a village in eastern Sudan. 2. Drug resistance, molecular karyotypes and the mdr1 genotype of recent isolates. Trans R Soc Trop Med Hyg (1992) 1.04
Iron metabolism and malaria. Food Nutr Bull (2007) 1.04
Mixed Plasmodium falciparum infections and its clinical implications in four areas of the Brazilian Amazon region. Acta Trop (2008) 1.03
Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial. PLoS One (2011) 0.99
Antimalarial activity of selected aromatic chelators. Mol Pharmacol (1980) 0.95
Iron overload increases hepatic development of Plasmodium yoelii in mice. Parasitology (1996) 0.95
Erythropoietin production in virulent malaria. Infect Immun (1974) 0.92
Antimalarial activity of selected aromatic chelators. II. Substituted quinolines and quinoline-N-oxides. Mol Pharmacol (1981) 0.91
Parasitology. Malaria vaccines: back to the future? Science (2005) 0.90
Iron chelators: mode of action as antimalarials. Acta Haematol (1996) 0.90
Antimalarial activity of selected aromatic chelators. III. 8-Hydroxyquinolines (oxines) substituted in positions 5 and 7, and oxines annelated in position 5,6 by an aromatic ring. Mol Pharmacol (1982) 0.87
Assessment of the effect of the oral iron chelator deferiprone on asymptomatic Plasmodium falciparum parasitemia in humans. Am J Trop Med Hyg (1998) 0.83
Malaria and iron: history and review. Drug Metab Rev (2009) 0.81
Effects of iron deficiency on the hepatic development of Plasmodium yoelii. Parasite (1995) 0.81
Plasmodicidal effect of desferrioxamine B in human vivax or falciparum malaria from Thailand. Acta Trop (1992) 0.80
Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells. Blood (1996) 0.78
Plasmodium falciparum and Plasmodium yoelii: effect of the iron chelation prodrug dexrazoxane on in vitro cultures. Exp Parasitol (1999) 0.77
Effects of synthetic siderophores on proliferation of Plasmodium falciparum in infected human erythrocytes. Antimicrob Agents Chemother (2002) 0.77
Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med (2007) 4.22
Control of iron deficiency anemia in low- and middle-income countries. Blood (2013) 2.99
The silent path to thousands of merozoites: the Plasmodium liver stage. Nat Rev Microbiol (2006) 2.83
Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc Natl Acad Sci U S A (2005) 2.71
Host-mediated regulation of superinfection in malaria. Nat Med (2011) 2.57
Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc Natl Acad Sci U S A (2005) 2.49
Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication. Nat Immunol (2007) 2.43
Apoptotic Plasmodium-infected hepatocytes provide antigens to liver dendritic cells. J Infect Dis (2005) 2.42
Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging. PLoS One (2009) 2.18
In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood (2005) 1.96
A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell Host Microbe (2013) 1.95
Malaria blood stage suppression of liver stage immunity by dendritic cells. J Exp Med (2003) 1.78
Hepcidin regulation by innate immune and infectious stimuli. Blood (2011) 1.63
Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection. Cell Host Microbe (2008) 1.62
Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood (2012) 1.57
Host cell transcriptional profiling during malaria liver stage infection reveals a coordinated and sequential set of biological events. BMC Genomics (2009) 1.52
Dissecting in vitro host cell infection by Plasmodium sporozoites using flow cytometry. Cell Microbiol (2007) 1.50
Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection. Cell Host Microbe (2008) 1.50
Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice. Infect Immun (2010) 1.47
Hepatocyte growth factor and its receptor are required for malaria infection. Nat Med (2003) 1.37
HIV-1 down-regulates the expression of CD1d via Nef. Eur J Immunol (2006) 1.36
The relevance of non-human primate and rodent malaria models for humans. Malar J (2011) 1.36
Liver-stage malaria parasites vulnerable to diverse chemical scaffolds. Proc Natl Acad Sci U S A (2012) 1.31
HGF/MET signalling protects Plasmodium-infected host cells from apoptosis. Cell Microbiol (2005) 1.28
VEGF promotes malaria-associated acute lung injury in mice. PLoS Pathog (2010) 1.28
Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. Int J Parasitol (2007) 1.24
Kinome-wide RNAi screen implicates at least 5 host hepatocyte kinases in Plasmodium sporozoite infection. PLoS Pathog (2008) 1.20
PSLAP, a protein with multiple adhesive motifs, is expressed in Plasmodium falciparum gametocytes. Mol Biochem Parasitol (2002) 1.20
Drug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drug. J Infect Dis (2012) 1.18
Plasmodium berghei parasite transformed with green fluorescent protein for screening blood schizontocidal agents. Int J Parasitol (2004) 1.18
A toolbox to study liver stage malaria. Trends Parasitol (2011) 1.16
Adenylyl cyclase alpha and cAMP signaling mediate Plasmodium sporozoite apical regulated exocytosis and hepatocyte infection. PLoS Pathog (2008) 1.16
Localisation of proteins of iron metabolism in the human placenta and liver. Br J Haematol (2006) 1.16
Plasmodium falciparum infected erythrocytes induce hepcidin (HAMP) mRNA synthesis by peripheral blood mononuclear cells. Br J Haematol (2009) 1.15
Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii. Mol Biochem Parasitol (2006) 1.14
Interactions of the malaria parasite and its mammalian host. Curr Opin Microbiol (2008) 1.11
Expression of the iron hormone hepcidin distinguishes different types of anemia in African children. Sci Transl Med (2014) 1.10
Cerebral malaria and the hemolysis/methemoglobin/heme hypothesis: shedding new light on an old disease. Int J Biochem Cell Biol (2008) 1.09
Implications of malaria on iron deficiency control strategies. Adv Nutr (2012) 1.07
Transition of Plasmodium sporozoites into liver stage-like forms is regulated by the RNA binding protein Pumilio. PLoS Pathog (2011) 1.06
The IFN-γ-inducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens. PLoS One (2011) 1.06
Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one? Infect Immun (2007) 1.05
Torins are potent antimalarials that block replenishment of Plasmodium liver stage parasitophorous vacuole membrane proteins. Proc Natl Acad Sci U S A (2013) 1.05
The next opportunity in anti-malaria drug discovery: the liver stage. PLoS Pathog (2011) 1.04
A novel flow cytometric hemozoin detection assay for real-time sensitivity testing of Plasmodium falciparum. PLoS One (2013) 1.00
A novel carbon monoxide-releasing molecule fully protects mice from severe malaria. Antimicrob Agents Chemother (2011) 0.99
Genistein-supplemented diet decreases malaria liver infection in mice and constitutes a potential prophylactic strategy. PLoS One (2008) 0.97
Simple flow cytometric detection of haemozoin containing leukocytes and erythrocytes for research on diagnosis, immunology and drug sensitivity testing. Malar J (2011) 0.97
Targeting the liver stage of malaria parasites: a yet unmet goal. J Med Chem (2011) 0.96
Innate recognition of malarial parasites by mammalian hosts. Int J Parasitol (2012) 0.93
Crystal structure of arginase from Plasmodium falciparum and implications for L-arginine depletion in malarial infection . Biochemistry (2010) 0.92
Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload. Lancet (2002) 0.92
Antimalarial drugs - host targets (re)visited. Biotechnol J (2006) 0.92
Quantification of sporozoite invasion, migration, and development by microscopy and flow cytometry. Methods Mol Biol (2013) 0.92
Use of a selective inhibitor to define the chemotherapeutic potential of the plasmodial hexose transporter in different stages of the parasite's life cycle. Antimicrob Agents Chemother (2011) 0.91
A small molecule inhibitor of signal peptide peptidase inhibits Plasmodium development in the liver and decreases malaria severity. PLoS One (2009) 0.90
Ferroportin: lack of evidence for multimers. Blood Cells Mol Dis (2007) 0.87
Unlike the synchronous Plasmodium falciparum and P. chabaudi infection, the P. berghei and P. yoelii asynchronous infections are not affected by melatonin. Int J Gen Med (2009) 0.87
Targeting host factors to circumvent anti-malarial drug resistance. Curr Pharm Des (2013) 0.86
Early skin immunological disturbance after Plasmodium-infected mosquito bites. Cell Immunol (2012) 0.83
Bone marrow chimeric mice reveal a dual role for CD36 in Plasmodium berghei ANKA infection. Malar J (2007) 0.82
Hypoxia promotes liver-stage malaria infection in primary human hepatocytes in vitro. Dis Model Mech (2013) 0.82
Severe malaria increases the list of heme oxygenase-1-protected diseases. Future Microbiol (2007) 0.82
Design and evaluation of primaquine-artemisinin hybrids as a multistage antimalarial strategy. Antimicrob Agents Chemother (2011) 0.81
Incorporation of basic side chains into cryptolepine scaffold: structure-antimalarial activity relationships and mechanistic studies. J Med Chem (2011) 0.81
Imidazoquines as antimalarial and antipneumocystis agents. J Med Chem (2009) 0.80
Gold nanoparticle-based fluorescence immunoassay for malaria antigen detection. Anal Bioanal Chem (2011) 0.80
In Vivo Hemozoin Kinetics after Clearance of Plasmodium berghei Infection in Mice. Malar Res Treat (2012) 0.80
Infection by Plasmodium changes shape and stiffness of hepatic cells. Nanomedicine (2011) 0.79
Immunization with genetically attenuated P52-deficient Plasmodium berghei sporozoites induces a long-lasting effector memory CD8+ T cell response in the liver. J Immune Based Ther Vaccines (2011) 0.79
Quinolin-4(1H)-imines are potent antiplasmodial drugs targeting the liver stage of malaria. J Med Chem (2013) 0.79
Infection by and protective immune responses against Plasmodium berghei ANKA are not affected in macrophage scavenger receptors A deficient mice. BMC Microbiol (2006) 0.79
Highly dynamic host actin reorganization around developing Plasmodium inside hepatocytes. PLoS One (2012) 0.79
Survival of protozoan intracellular parasites in host cells. EMBO Rep (2004) 0.79
In vitro binding of HFE to the cation-independent mannose-6 phosphate receptor. Blood Cells Mol Dis (2009) 0.79
To migrate or to invade: those are the options. Cell Host Microbe (2007) 0.78
Phosphothioate oligodeoxynucleotides inhibit Plasmodium sporozoite gliding motility. Cell Microbiol (2009) 0.78
Assessment of dual life stage antiplasmodial activity of british seaweeds. Mar Drugs (2013) 0.78
The relevance of host genes in malaria. SEB Exp Biol Ser (2007) 0.77
Plasmodium berghei-infection induces volume-regulated anion channel-like activity in human hepatoma cells. Cell Microbiol (2009) 0.76
Induced Disruption of the Iron-Regulatory Hormone Hepcidin Inhibits Acute Inflammatory Hypoferraemia. J Innate Immun (2016) 0.76
Flavones as isosteres of 4(1H)-quinolones: discovery of ligand efficient and dual stage antimalarial lead compounds. Eur J Med Chem (2013) 0.76
Next-Generation Biomarkers for Iron Status. Nestle Nutr Inst Workshop Ser (2016) 0.76
Intravenous iron and vertical HIV transmission: any connection? AIDS (2014) 0.75
Plasmodium Cysteine Repeat Modular Proteins 3 and 4 are essential for malaria parasite transmission from the mosquito to the host. Malar J (2011) 0.75
Multifactorial iron man. Digestion (2005) 0.75
Chemical interrogation of the malaria kinome. Chembiochem (2014) 0.75
Reflecting on a quarter century of HIV research. Nat Immunol (2008) 0.75
Structural optimization of quinolon-4(1H)-imines as dual-stage antimalarials: toward increased potency and metabolic stability. J Med Chem (2013) 0.75